Literature DB >> 8537493

Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis.

R Olsson1, I Hägerstrand, U Broomé, A Danielsson, G Järnerot, L Lööf, H Prytz, B O Rydén, S Wallerstedt.   

Abstract

AIMS: To study sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis (PSC).
METHODS: One hundred and twelve biopsy specimens (that is, 56 pairs) from 44 patients with PSC, confirmed by cholangiography, were evaluated blindly. Six different features, qualitative grading of four other features and staging according to Ludwig were assessed.
RESULTS: Quantitative sampling variability was confined mainly to just one grade or stage, although 11% (six of 56) of the biopsy specimen pairs differed by more than one stage (7% (one of 15) in pairs > 2 cm in length). Qualitative sampling variabilities were between 18 and 71%. Advanced disease (stages 3 or 4) was missed in 40% (two of five) of the biopsy specimens while cirrhosis was missed in 37%.
CONCLUSION: Paired liver biopsy specimens should be taken in clinical studies of PSC using liver histology for evaluation or prognosis.

Entities:  

Mesh:

Year:  1995        PMID: 8537493      PMCID: PMC502950          DOI: 10.1136/jcp.48.10.933

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Accuracy of sampling by needle biopsy in diffuse liver disease.

Authors:  S S WALDSTEIN; P B SZANTO
Journal:  Arch Pathol (Chic)       Date:  1950-09

Review 2.  Surgical pathology of the syndrome of primary sclerosing cholangitis.

Authors:  J Ludwig
Journal:  Am J Surg Pathol       Date:  1989       Impact factor: 6.394

3.  Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy.

Authors:  R D Soloway; A H Baggenstoss; L J Schoenfield; W H Summerskill
Journal:  Am J Dig Dis       Date:  1971-12

4.  [Correlation of the laparoscopic and histological findings in chronic hepatitis and liver cirrhosis].

Authors:  I Vido; E Wildhirt
Journal:  Dtsch Med Wochenschr       Date:  1969-08-15       Impact factor: 0.628

5.  Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.

Authors:  B Maharaj; R J Maharaj; W P Leary; R M Cooppan; A D Naran; D Pirie; D J Pudifin
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

6.  Histological features of sclerosing cholangitis in patients with chronic ulcerative colitis.

Authors:  C Barbatis; P Grases; H A Shepherd; R W Chapman; J Trowell; D P Jewell; J O McGee
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

7.  Sampling variability on percutaneous liver biopsy.

Authors:  W Abdi; J C Millan; E Mezey
Journal:  Arch Intern Med       Date:  1979-06

8.  The variation of pathological changes in the liver evaluated by double biopsies.

Authors:  P Baunsgaard; G C Sanchez; C J Lundborg
Journal:  Acta Pathol Microbiol Scand A       Date:  1979-01

Review 9.  Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  R H Wiesner; M K Porayko; E R Dickson; G J Gores; N F LaRusso; J E Hay; H E Wahlstrom; R A Krom
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

10.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.

Authors:  R W Chapman; B A Arborgh; J M Rhodes; J A Summerfield; R Dick; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

View more
  28 in total

1.  Asymptomatic primary sclerosing cholangitis with marked hepatic fibrosis.

Authors:  H Kawai; Y Aoyagi; M Nomoto; H Takizawa; Y Suzuki; A Hama; T Suda; T Takahashi; H Asakura
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Pathologists and gastroenterologists.

Authors:  Y Niv
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

3.  Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.

Authors:  Daniel L Motola; Peter Caravan; Raymond T Chung; Bryan C Fuchs
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

Review 4.  The management of primary sclerosing cholangitis.

Authors:  Roger W Chapman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 5.  Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy.

Authors:  Scott B Reeder; Irene Cruite; Gavin Hamilton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-09-16       Impact factor: 4.813

Review 6.  Quantification of liver fat with magnetic resonance imaging.

Authors:  Scott B Reeder; Claude B Sirlin
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

7.  Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population.

Authors:  C Y Ponsioen; S M E Vrouenraets; W Prawirodirdjo; R Rajaram; E A J Rauws; C J J Mulder; J B Reitsma; S H Heisterkamp; G N J Tytgat
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

8.  Diagnostic accuracy of intracellular uptake rates calculated using dynamic Gd-EOB-DTPA-enhanced MRI for hepatic fibrosis stage.

Authors:  Krishna Juluru; Andrew H Talal; Rhonda K Yantiss; Pascal Spincemaille; Elizabeth K Weidman; Ashley E Giambrone; Sadaf Jalili; Steven P Sourbron; Jonathan P Dyke
Journal:  J Magn Reson Imaging       Date:  2016-08-16       Impact factor: 4.813

9.  Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass.

Authors:  Janani Arun; Niraj Jhala; Audrey J Lazenby; Ronald Clements; Gary A Abrams
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

10.  The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis.

Authors:  Dai Zhang; Nian-Yue Wang; Cheng-Bao Yang; Guo-Xiang Fang; Wei Liu; Jian Wen; Chan Luo
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.